Recent News
Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it
A team led by UNC Lineberger's Gianpietro Dotti, MD, has engineered immune cells to hunt glioblastoma, the most lethal primary brain tumor. They presented their findings in Science Translational Medicine.
Mayer advising NCI on cancer survivorship issues and research
UNC Lineberger's Deborah K. Mayer, PhD, RN, AOCN, FAAN, will continue to work at UNC-Chapel Hill while providing counsel to the National Cancer Institute’s Division of Cancer Control and Population Sciences on issues related to cancer survivorship.
Sellers named 2018 Health Care Hero
Triangle Business Journal recognizes Jean Sellers, RN, MSN, for her work to improve access to high quality cancer care in North Carolina.
Phase I clinical trial shows some promise for investigational drug for melanoma
Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.